Kungsör, Sweden

Patrik Rhönnstad

USPTO Granted Patents = 4 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Kungsör, SE (2009 - 2014)
  • Kungsor, SE (2014)

Company Filing History:


Years Active: 2009-2014

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Patrik Rhönnstad

Introduction

Patrik Rhönnstad is a notable inventor based in Kungsör, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of estrogen receptor ligands. With a total of 4 patents to his name, Rhönnstad's work has the potential to impact the treatment of various conditions associated with estrogen receptor activity.

Latest Patents

Rhönnstad's latest patents focus on compounds that serve as estrogen receptor ligands. The first patent describes a compound of formula (I) or a pharmaceutically acceptable ester, amide, solvate, or salt thereof. This invention also outlines the use of such compounds in the treatment or prophylaxis of conditions related to diseases or disorders associated with estrogen receptor activity. The second patent similarly details a compound of formula (I) or a pharmaceutically acceptable ester, amide, carbamate, solvate, or salt thereof, emphasizing its therapeutic applications.

Career Highlights

Throughout his career, Patrik Rhönnstad has worked with prominent companies in the pharmaceutical industry, including Karo Bio AB and Wyeth. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Rhönnstad has collaborated with notable colleagues such as Aiping Cheng and Theresa Apelqvist. These partnerships have likely enriched his research and development efforts in the field of pharmaceuticals.

Conclusion

Patrik Rhönnstad's innovative work in the development of estrogen receptor ligands showcases his significant contributions to the pharmaceutical industry. His patents reflect a commitment to advancing medical treatments and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…